Education
About Us
Working with TipRanks
Follow Us
Christopher Grant Doughty Insider Profile
4 Followers
Christopher Grant Doughty, Chief Business Officer at Crescent Biopharma, holds 62.19K shares in Crescent Biopharma (Ticker: CBIO).
Christopher Grant Doughty has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christopher Grant Doughty's holdings
Insider Roles
Chief Business Officer
Roles that Christopher Grant Doughty holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Christopher Grant Doughty
Christopher Grant Doughty's Trading History
List of latest transactions for each holding click on a transaction to see Christopher Grant Doughty's performance on stock
You May Also Like
Christopher Grant Doughty insider profile FAQ
What is the percentage of profitable transactions made by Christopher Grant Doughty?
The percentage of profitable transactions made by Christopher Grant Doughty is ―.
What is the average return per transaction made by Christopher Grant Doughty?
The average return per transaction made by Christopher Grant Doughty is ―.
What stocks does Christopher Grant Doughty hold?
Christopher Grant Doughty holds: CBIO stocks.
What was Christopher Grant Doughty’s latest transaction?
Christopher Grant Doughty latest transaction was an Uninformative Buy of ―.
What was Christopher Grant Doughty's most profitable transaction?
Christopher Grant Doughty’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Christopher Grant Doughty's role in Crescent Biopharma?
Christopher Grant Doughty's role in Crescent Biopharma is Chief Business Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.